Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First-in-human Clinical Study of Mts105 for Advanced Hepatocellular Carcinoma

NCT06689540 is registered in ClinicalTrials.gov with Shen Lin as lead sponsor.

NCT NCT06689540
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06689540 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First-in-human Clinical Study of Mts105 for Advanced Hepatocellular Carcinoma
Lead sponsor
Shen Lin
Phase
Phase 1
Overall status
Recruiting
Start date
November 18, 2024
Completion date
December 31, 2026
Enrollment
14 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hcc - hepatocellular carcinoma, hepatocellular carcinoma (hcc), liver cancer, adult, metastatic liver cancers